Gang Zeng
Company: T-Cure Biosciences Inc.
Job title: Chief Executive Officer
Seminars:
Panel Discussion: Advancing Beyond HLA 201 – strategies for Delivery to a Wider Patient Population 2:30 pm
day: Day One
Developing MHC Class II Restricted TCRs for Action in Solid Tumor Settings 1:30 pm
day: Day One